Clinical and Biological Characteristics of Severe Malaria in Children under 5 Years Old in Benin

Xiao Ma1,2, Xin Fan3, Kora Chabi Youssaou4

  • 1Department of Emergency, General Hospital, Ningxia Medical University, Yinchuan, China.

Insights

Severe pediatric malaria in Benin disproportionately affects young children, presenting with symptoms like severe anemia and vomiting. High fatality rates underscore the urgent need for improved prevention and early treatment strategies.

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Malariology

Background:

  • Malaria poses a significant global health threat, particularly in sub-Saharan Africa.
  • Pediatric malaria cases are prone to severe, potentially fatal outcomes.
  • The COVID-19 pandemic complicated malaria diagnosis and treatment in 2020.

Purpose of the Study:

  • To analyze clinical characteristics and laboratory indicators of severe pediatric malaria in Benin.
  • To inform the development of effective prevention and treatment strategies for pediatric malaria.
  • To assess the impact of the COVID-19 pandemic on malaria case management.

Main Methods:

  • Retrospective analysis of 236 pediatric severe malaria cases from two hospitals in Benin (January-December 2020).
  • Patients were categorized into age groups (4-12 months, 13-36 months, 37-60 months).
  • Comparison of clinical and laboratory indicators across age groups, including incidence and mortality rates.

Main Results:

  • Severe anemia, vomiting, prostration, and dyspnea were common symptoms.
  • Vomiting and severe anemia were prevalent in infants (4-12 months).
  • Older children (37-60 months) showed higher delirium rates, higher hemoglobin/hematocrit, lower leukocyte counts, and higher parasitemia.

Conclusions:

  • Severe pediatric malaria in Benin exhibits seasonal patterns and a high fatality rate in children under five.
  • Urgent implementation of preventative measures and prompt, appropriate treatment is crucial.
  • Addressing the severe disease burden and high mortality in pediatric malaria patients is a priority.
Abstract